# Santyl vs. Sharp Debridement of Diabetic Foot Wounds

> **NCT01056198** · PHASE4 · COMPLETED · sponsor: **Healthpoint** · enrollment: 48 (actual)

## Conditions studied

- Diabetic Foot Ulcers
- Foot Wounds

## Interventions

- **DRUG:** Santyl
- **PROCEDURE:** Control

## Key facts

- **NCT ID:** NCT01056198
- **Lead sponsor:** Healthpoint
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-08
- **Final completion:** 2011-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056198, "Santyl vs. Sharp Debridement of Diabetic Foot Wounds". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01056198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*